Journal of Virology · 2018 · 59 citations · 44 references
Life SciencesImmunologyPediatricsPediatric ImmunologyVaccine ImmunologyVaccinologyAdaptive Immune ResponsesAntigen DesignAntiviral ImmunityHiv Vaccine DevelopmentHumoral ImmunityViral VaccinesAntibody Lineage DevelopmentHiv Envelope Glycoprotein AntigensNeutralizationPeptide EpitopesPreventive Hiv VaccinesVaccine Immunogen Design
An HIV vaccine is likely to require bNAbs, which have been shown to prevent HIV acquisition in nonhuman primates. Recent evidence suggests that HIV-infected children are inherently better at generating bNAbs than adults. Here, we show that exceptional neutralization breadth in a group of viremic HIV-1 subtype C-infected children was due to the presence of polyclonal bNAb responses. These bNAbs targeted multiple epitopes on the HIV envelope glycoprotein previously defined in adult infection, suggesting that the immature immune system recognizes HIV antigens similarly. Since elicitation of a polyclonal bNAb response is the basis of next-generation HIV envelope vaccines, further studies of how bNAb lineages are stimulated in children is warranted. Furthermore, our findings suggest that children may respond particularly well to vaccines designed to elicit antibodies to multiple bNAb epitopes.
44
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
Jinghe Huang, Gilad Ofek, Leo Laub et al. · Nature · 2012 · 847 citations · Full text
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
Nicole A. Doria‐Rose, Chaim A. Schramm, Jason Gorman et al. · Nature · 2014 · 752 citations · Full text
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
Robert Pejchal, Katie J. Doores, Laura M. Walker et al. · Science · 2011 · 704 citations